FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094812230> ?p ?o ?g. }

• W2094812230 abstract "Purpose: Male breast cancer (MBC) is extremely rare, accounting for less than 1% of all malignancies in men and only 1% of all breast carcinomas. The treatment and surveillance guidelines on male breast cancers are less recognized. The aim of this study is to evaluate our single institution9s experience with MBC over the past 15 years and to contrast differences between female and MBC. Methods: MBC diagnosed from 1994 to 2010 at the Department of Surgery, Samsung Medical Center (Seoul, Korea) was retrospectively analyzed. Clinical data and tumor characteristics were examined. Each MBC was matched with female counterparts by 1:N varied matching ratio that showed accordance in seven variables (year of diagnosis, age, tumor stage, nodal stage, tumor grade, estrogen receptor(ER), progesterone receptor(PR)). Results: 39 male/184 female matched-pairs were available for analysis. The median duration of follow-up was 3.8 years. The median age of MBC patients was 50 years and the median size of tumor was 2.0cm. The proportion of positivity of ER and PR status was 97.4% and 84.6%, respectively. Despite of higher positive rate of hormone receptor, the rate of hormone therapy in MBC patients was significant lower than female conterpart (p = 0.002). Men and women with breast cancer had similar disease-free survival (DFS) and disease-specific overall survival (DSS). Five MBC patients had a recurrence during follow up period and 4 of them were expired. The 10-years DFS was 73.1% in men and 80.5% in women (p = 0.348). The 10-years DSS was 74.1% in men and 87.1% in women, respectively (p = 0.207). Conclusion: This study showed no disease free and overall survival differences between male and female breast cancer patients and revealed that gender is no predictor for survival in breast cancer. Male patients receive obviously less adjuvant treatment compared their female matched patients. It would be better to do more aggressive treatment in MBC to improve the survival outcome. Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P3-11-01." @default.
• W2094812230 created "2016-06-24" @default.
• W2094812230 creator A5005581658 @default.
• W2094812230 creator A5021757277 @default.
• W2094812230 creator A5045863545 @default.
• W2094812230 creator A5050810206 @default.
• W2094812230 creator A5051337101 @default.
• W2094812230 creator A5058283198 @default.
• W2094812230 creator A5062982882 @default.
• W2094812230 creator A5067658288 @default.
• W2094812230 creator A5080222514 @default.
• W2094812230 creator A5081740770 @default.
• W2094812230 date "2012-12-15" @default.
• W2094812230 modified "2023-09-26" @default.
• W2094812230 title "Abstract P3-11-01: Matched-pair analysis of patients with male and female breast cancer" @default.
• W2094812230 doi "https://doi.org/10.1158/0008-5472.sabcs12-p3-11-01" @default.
• W2094812230 hasPublicationYear "2012" @default.
• W2094812230 type Work @default.
• W2094812230 sameAs 2094812230 @default.
• W2094812230 citedByCount "0" @default.
• W2094812230 crossrefType "proceedings-article" @default.
• W2094812230 hasAuthorship W2094812230A5005581658 @default.
• W2094812230 hasAuthorship W2094812230A5021757277 @default.
• W2094812230 hasAuthorship W2094812230A5045863545 @default.
• W2094812230 hasAuthorship W2094812230A5050810206 @default.
• W2094812230 hasAuthorship W2094812230A5051337101 @default.
• W2094812230 hasAuthorship W2094812230A5058283198 @default.
• W2094812230 hasAuthorship W2094812230A5062982882 @default.
• W2094812230 hasAuthorship W2094812230A5067658288 @default.
• W2094812230 hasAuthorship W2094812230A5080222514 @default.
• W2094812230 hasAuthorship W2094812230A5081740770 @default.
• W2094812230 hasConcept C121608353 @default.
• W2094812230 hasConcept C126322002 @default.
• W2094812230 hasConcept C143998085 @default.
• W2094812230 hasConcept C146357865 @default.
• W2094812230 hasConcept C151730666 @default.
• W2094812230 hasConcept C2777396416 @default.
• W2094812230 hasConcept C29456083 @default.
• W2094812230 hasConcept C530470458 @default.
• W2094812230 hasConcept C71924100 @default.
• W2094812230 hasConcept C84606932 @default.
• W2094812230 hasConcept C86803240 @default.
• W2094812230 hasConcept C90924648 @default.
• W2094812230 hasConceptScore W2094812230C121608353 @default.
• W2094812230 hasConceptScore W2094812230C126322002 @default.
• W2094812230 hasConceptScore W2094812230C143998085 @default.
• W2094812230 hasConceptScore W2094812230C146357865 @default.
• W2094812230 hasConceptScore W2094812230C151730666 @default.
• W2094812230 hasConceptScore W2094812230C2777396416 @default.
• W2094812230 hasConceptScore W2094812230C29456083 @default.
• W2094812230 hasConceptScore W2094812230C530470458 @default.
• W2094812230 hasConceptScore W2094812230C71924100 @default.
• W2094812230 hasConceptScore W2094812230C84606932 @default.
• W2094812230 hasConceptScore W2094812230C86803240 @default.
• W2094812230 hasConceptScore W2094812230C90924648 @default.
• W2094812230 hasLocation W20948122301 @default.
• W2094812230 hasOpenAccess W2094812230 @default.
• W2094812230 hasPrimaryLocation W20948122301 @default.
• W2094812230 isParatext "false" @default.
• W2094812230 isRetracted "false" @default.
• W2094812230 magId "2094812230" @default.
• W2094812230 workType "article" @default.